Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Abdominal Cancer
62%
Adenoma
16%
Artificial Intelligence
25%
Capsule Endoscopy
28%
Cholangitis
12%
Cholescintigraphy
12%
Chronic Hepatitis B
12%
Cohort Effect
37%
Colon
27%
Colonoscopy
47%
Colorectal Cancer Screening
37%
Colorectal Carcinoma
12%
Comorbidity
9%
Diglycine
12%
Disease Exacerbation
14%
Disease Predisposition
25%
Disease Prevalence
25%
Endoscopic Retrograde Cholangiopancreatography
12%
Esophagogastroduodenoscopy
25%
Ethnic Group
9%
Fibrosis
12%
functional dyspepsia
25%
Geriatrics
12%
Guaiacum
18%
Helicobacter Infection
10%
Hepatitis B
31%
Hepatitis B Virus
25%
Hepatitis B(e) Antibody
14%
Hepatitis B(e) Antigen
12%
Hepatitis C
12%
Hepatitis C Virus
12%
Infection
12%
Infliximab
25%
Internal Medicine
12%
Liver Disease
14%
Longitudinal Study
12%
Mixed Infection
12%
Neoplasm
14%
Obesity Medicine
12%
Occult Blood Test
18%
Polyp
9%
Pouchitis
25%
Prevalence
39%
Prospective Cohort Study
62%
Scintigraphy
12%
Sickle-Cell Disease
25%
Spleen Function
16%
Stomach Lesion
62%
Upper Digestive Tract
25%
Virus DNA
9%
Immunology and Microbiology
Adolescence
12%
Alanine
6%
Alanine Aminotransferase Blood Level
6%
Allele
12%
Awareness
6%
Cell Membrane
6%
Cohort Effect
12%
Coinfection
25%
Drug Dose Reduction
7%
Epidemiology
12%
Gene Frequency
6%
Glycoprotein
6%
Granulocyte Colony-Stimulating Factor
25%
HBsAg
52%
HBV DNA
25%
Helicobacter Pylori
12%
Hepatitis B
100%
Hepatitis B Antigen
52%
Hepatitis B Virus
72%
Hepatitis B(e) Antibody
28%
Hepatitis B(e) Antigen
52%
Hepatitis C
53%
Hepatitis C Virus
31%
Hepatitis Virus
10%
Host Cell
6%
Infection
65%
Infectious Disease
65%
Lipid Homeostasis
12%
Neutrophil
10%
Prevalence
11%
Restriction Fragment Length Polymorphism
6%
Ribonucleic Acid
25%
Seroconversion
22%
Viral Replication
6%
Viremia
6%
Virus Infectivity
6%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
12%
Adverse Event
12%
Chronic Hepatitis B
37%
Chronic Hepatitis C
53%
Cohort Study
25%
Colon Carcinoma
12%
Diglycine
25%
Disease Exacerbation
12%
Effusion
6%
Fibrosis
28%
Glycoprotein
6%
Granulocyte Colony Stimulating Factor
25%
Guaiac
5%
Hepatitis B
47%
Hepatitis B Antigen
30%
Hepatitis B Virus
62%
Hepatitis B(e) Antibody
24%
Hepatitis B(e) Antigen
39%
Hepatitis C
28%
Hepatitis C Virus
35%
Hyperlipidemia
25%
Infection
69%
Lipid
18%
Liver Cirrhosis
12%
Liver Disease
20%
Mebrofenin
11%
Mixed Infection
7%
Neutropenia
25%
Prospective Cohort Study
25%
Ribavirin
11%
Sofosbuvir
33%
Technetium 99m
12%
Vertical Transmission
6%
Virus
25%
Virus DNA
27%